SCHEMBL7879962

SCHEMBL7879962

CNC(N)=NC(=O)c1cc2cc(C)ccc2[nH]1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIN1 Q13526 1/20 0.56
FLT3 P36888 4/20 0.51
PDGFRB P09619 1/20 0.51
PDGFRA P16234 1/20 0.51
RAB9A P51151 3/20 0.50
TP53 P04637 2/20 0.50
KDM4E B2RXH2 1/20 0.50
ALDH1A1 P00352 1/20 0.50
HPGD P15428 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
HSD17B10 Q99714 1/20 0.50
POLB P06746 1/20 0.50
NPC1 O15118 2/20 0.48
RXFP1 Q9HBX9 1/20 0.48
HRH4 Q9H3N8 1/20 0.46
CDK4 P11802 1/20 0.45
AKR1C3 P42330 2/20 0.44
HDAC1 Q13547 1/20 0.43
HDAC2 Q92769 1/20 0.43
MEN1 O00255 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7877619 0.99 PIN1 (0.55) PIN1FLT3PDGFRBPDGFRARAB9A
SCHEMBL7882077 0.89 FLT3 (0.48) PIN1FLT3PDGFRBPDGFRATP53
Hydrochloric Acid SCHEMBL7880750 0.88 FLT3 (0.47) PIN1FLT3PDGFRBPDGFRATP53
SCHEMBL7878275 0.86 HRH4 (0.48) PIN1FLT3PDGFRBPDGFRAKDM4E
SCHEMBL7873277 0.86 FLT3 (0.55) FLT3PDGFRBPDGFRAHRH4
SCHEMBL7877880 0.85 F7 (0.55) FLT3RAB9ANPC1RXFP1HRH4
Hydrochloric Acid SCHEMBL7877524 0.85 FLT3 (0.54) FLT3PDGFRBPDGFRAHRH4
Hydrochloric Acid SCHEMBL7881764 0.85 HRH4 (0.47) PIN1FLT3PDGFRBPDGFRAKDM4E
Hydrochloric Acid SCHEMBL7877845 0.84 KDM4E (0.54) FLT3RAB9AKDM4EALDH1A1HPGD
Hydrochloric Acid SCHEMBL7873363 0.84 F7 (0.54) FLT3RAB9ANPC1RXFP1HRH4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6248772-B1 HYPOTENSIVE AGENTS; ANTIARRHYTHMIA AGENTS; ANTIDIABETIC AGENTS; ANTIPROLIFERATIVE AGENTS SUMITOMO PHARMACEUTICALS CO., LTD. (JP) 2001-06-19 US disclosed
US-6169107-B1 USEFUL FOR THE TREATMENT AND PREVENTION OF DISEASES CAUSED BY INCREASED SODIUM/PROTON (NA.SUP.+ /H.SUP.+) EXCHANGER ACTIVITY, FOR EXAMPLE, HYPERTENSION, ARRHYTHMIA, ANGINA PECTORIS, CARDIAC HYPERTROPHY, DIABETES MELLITUS SUMITOMO PHARMACEUTICAL CO., LTD. (JP) 2001-01-02 US disclosed
EP-0622356-B1 Indoloylguanidine derivatives as inhibitors of sodium-hydrogen exchange SUMITOMO PHARMA (JP) 1998-07-01 EP disclosed
CN-1136038-A Indoloylguanidine derivatives SUMITOMO PHARMACEUTICS K K (JP) 1996-11-20 CN disclosed
EP-0708091-A2 Indoloylguanidine derivatives SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1996-04-24 EP disclosed
CN-1106800-A Indoloylguanidine derivatives SUMITOMO PHARMA (JP) 1995-08-16 CN disclosed
EP-0622356-A1 Indoloylguanidine derivatives as inhibitors of sodium-hydrogen exchange SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1994-11-02 EP disclosed